Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Spotlight

GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines

Business

Deals
Earnings
Manufacturing

Policy & Regulation

Regulatory Landscape
Drug Pricing
IP & Litigation

Tools & Trackers

What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings

Conference Coverage

Partner Insights

Generics Bulletin Perspectives

Exploring market-shifting topics for the off-patent sector.

Generics Bulletin

Medtech Insight

USTR’s Special 301 Report Goes After India And China On IP

Apr 30 2019

• By David Wallace

World map — The US Report Details Grievances With IP Regimes Worldwide • Source: Shutterstock

Related Content

US slams India and China again

May 04 2018

Canada cannot do enough for USTR and originators

May 18 2018

Canadian industry is seeking lower costs and improvements

Oct 26 2018

Canada agrees to add to bio data exclusivity

Oct 05 2018

Additional Topics

China Asia Pacific India United States Canada Intellectual Property Regulation BioPharmaceutical

More from Legal & IP

More from Generics Bulletin

Twitter feed RSS feed RSS feed

About

About UsOpens in new window
Meet the Team
AdvertiseOpens in new window
Contact Us

Account

My Account
My View
Email Preferences
Start Free TrialOpens in new window

More

Generics Top 50 Ranking
Biosimilars
Generics
Value Added Medicines

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window